Cardiogenic shock is the heart failing as a pump. It is a medical emergency, not a chronic condition to be managed with lifestyle changes, and the single biggest determinant of survival is how fast normal blood flow is restored. This article covers what it is, how to recognise it, and what treatment actually involves — and it is explicit about where supplements have no role at all.
What cardiogenic shock actually is
Cardiogenic shock occurs when the heart muscle is too weak or too damaged to pump enough blood to keep organs perfused. Blood pressure falls, tissue oxygen delivery drops, and organs begin to fail. It is the most severe form of heart failure and one of the most lethal presentations in cardiology (Sarma, 2024).
The most common trigger is a large heart attack: when a coronary artery blocks, the muscle it supplies dies, and if enough muscle is lost the pump fails (Samsky, 2021).
It is rare compared with ordinary heart disease, which is why recognition matters more than prevention advice. Most people who develop it have known risk factors — but the presentation is acute, and the decisions that save lives are made in the first hours.
How it differs from other kinds of shock
“Shock” means inadequate tissue perfusion, and it has four main causes. Distinguishing them matters because the treatments are completely different — and giving the wrong one can be harmful.
| Type | Underlying problem | Typical trigger |
|---|---|---|
| Cardiogenic | The pump has failed | Large heart attack, severe arrhythmia, cardiomyopathy |
| Hypovolaemic | Not enough volume in the system | Severe bleeding, dehydration, burns |
| Septic | Vessels dilate and leak during overwhelming infection | Sepsis |
| Obstructive | Something physically blocks flow | Pulmonary embolism, cardiac tamponade, tension pneumothorax |
The practical difference: hypovolaemic shock is treated with fluid and blood, while cardiogenic shock is often made worse by large fluid volumes because the failing pump cannot move them. That is why this distinction is not academic — it changes what happens in the ambulance and the emergency department.
Symptoms to recognise
Early warning signs
- Shortness of breath, including at rest
- Sudden, extreme fatigue or weakness
- Cold, clammy, pale or mottled skin
- Weak, rapid pulse
- Confusion, agitation, or a sense of impending doom
- Reduced urine output
Signs that mean call an ambulance immediately
- Severe chest pain, especially crushing or radiating to the arm or jaw
- Gasping for air or inability to speak in full sentences
- Fainting or loss of consciousness
- Blue lips or fingertips
- Low blood pressure with confusion
What causes it
The dominant cause is a heart attack involving a large territory of muscle. Beyond that, the list is short but important:
- Acute myocardial infarction — by far the most common, particularly when a main coronary artery is occluded
- Severe arrhythmias — the heart beats but pumps ineffectively
- Cardiomyopathy — a primarily weak muscle, sometimes from prior damage
- Acute valve failure — sudden regurgitation or obstruction
- Myocarditis — inflammation of the muscle, sometimes viral
- Complications of cardiac surgery
What treatment actually involves
This is the section most consumer articles omit, and it is the one that matters. Cardiogenic shock is treated in an intensive care unit, and the goal is to restore perfusion while fixing the cause.
Restoring blood flow
When the cause is a blocked artery, the priority is emergency revascularisation — reopening the vessel by angioplasty and stenting, or bypass surgery. Current reviews are consistent that rapid revascularisation is the single most important intervention, and that delay worsens outcomes (Samsky, 2021), (Jung, 2024).
Supporting the circulation
Alongside that, treatment involves medications to support blood pressure and heart function, careful fluid management, and often mechanical circulatory support — devices that take over some of the pumping work so the heart can recover (Rob, 2021). The evidence for which device and in whom is actively evolving, and the guidance is that these decisions belong to a specialist team.
What the outcomes look like
Mortality remains high despite modern treatment, and contemporary reviews continue to describe it as one of the most lethal cardiac conditions (Shekhar, 2026). The strongest modifiable factor is time to treatment. That is why the public-health message is about recognition and calling for help early, not about anything you can do at home.
What about supplements in general, for the heart? Some have modest evidence in specific contexts — omega-3 for triglycerides, for example — but none substitutes for blood pressure control, cholesterol management, smoking cessation and exercise. The dietary side is covered in the heart-healthy food guide, and the risk-factor picture in cardiometabolic risk.
What else goes wrong
Cardiogenic shock is rarely a single-organ problem. When perfusion falls, everything downstream suffers, and the complications themselves become the reason someone dies rather than the original heart attack.
| Organ system | What happens | Why it matters |
|---|---|---|
| Kidneys | Reduced perfusion causes acute kidney injury, often compounded by diuretics and contrast used during procedures (Singh, 2021) | Dialysis may be needed; AKI strongly predicts worse outcome |
| Lungs | Fluid backs up into the lungs, causing pulmonary oedema | Breathlessness is often the dominant symptom; ventilation may be required |
| Liver and gut | Ischaemia from poor perfusion (“shock gut”) | Releases inflammatory mediators that worsen the spiral |
| Brain | Reduced cerebral perfusion | Confusion and agitation are early markers of severity |
| Heart rhythm | Arrhythmias from ischaemia and electrolyte disturbance | A common cause of deterioration in the first 24 hours |
The kidney is the organ most often discussed, because it fails early and because the treatment creates its own risks: the contrast used in angiography is nephrotoxic, and the diuretics used for fluid overload can worsen renal perfusion. That trade-off is one reason this is managed in intensive care by a specialist team rather than on a general ward.
Supporting a failing pump
Beyond opening the artery, treatment is about keeping organs perfused while the heart recovers. That typically means vasopressors and inotropes — drugs that raise blood pressure and strengthen contraction, respectively (Jentzer, 2021).
Norepinephrine is generally the first-line vasopressor in shock, on the basis of a landmark trial comparing it with dopamine, which found norepinephrine associated with fewer arrhythmic events (De Backer, 2010). Inotropes are used more cautiously, because they increase oxygen demand in a heart that may already be short of supply.
When drugs are not enough, mechanical circulatory support takes over some of the pumping work. The options range from an intra-aortic balloon pump through percutaneous ventricular assist devices to extracorporeal membrane oxygenation (ECMO). Use of ECMO in cardiogenic shock has grown substantially over the past decade, though the evidence for which patients benefit most is still being defined (Syed, 2022), (Rob, 2021).
Recovery, if you survive it
Surviving cardiogenic shock is the beginning of a long process rather than the end of one. Most people spend days to weeks in intensive care, often with mechanical support, and leave with substantial deconditioning.
Three things characterise the recovery period. Fatigue is profound and lasts months for many people, driven by both cardiac damage and the deconditioning of prolonged bed rest. Anxiety and low mood are common after an ICU stay, and are frequently undertreated. Cardiac rehabilitation — structured exercise and education — has good evidence for improving function and reducing readmission after cardiac events, and is worth asking about explicitly (Thompson, 2026).
Long-term management then looks like standard secondary prevention: medications, blood pressure and cholesterol control, smoking cessation, and gradual return to activity. The exercise side is covered in zone 2 training, and the dietary side in the heart-healthy food guide. Returning to exercise should be guided by the cardiac team rather than by enthusiasm.
Who is at higher risk
Risk factors for cardiogenic shock are essentially the risk factors for the heart disease that causes it:
- Previous heart attack or known coronary disease
- High blood pressure — see the blood pressure guide
- High cholesterol
- Diabetes and insulin resistance — see the insulin resistance checklist
- Smoking
- Obesity, particularly visceral fat — see visceral fat
- Age and family history
What prevention actually looks like
Prevention means preventing the heart attack, because that is the usual cause. That is unglamorous and well established: control blood pressure, manage cholesterol, do not smoke, keep moving, and treat diabetes seriously. The exercise evidence is in zone 2 training and walking for health.
Two things worth knowing that are not obvious. First, do not ignore symptoms that could be a heart attack because you are waiting for them to become unbearable — early presentation is what makes revascularisation possible. Second, women and people with diabetes can present atypically, which is covered in heart disease warning signs.
When to call emergency services
Call immediately if someone has:
- Chest pain or pressure lasting more than a few minutes, especially with sweating, nausea or breathlessness
- Severe shortness of breath at rest
- Fainting, or a collapse with no clear cause
- Cold, clammy skin with confusion or extreme weakness
- Blue lips or fingertips
While waiting: keep them still and calm, loosen tight clothing, do not give food or drink, do not give supplements or stimulants, and be ready to start CPR if they become unresponsive and stop breathing normally. If you are trained and a defibrillator is available, use it.
Common questions about cardiogenic shock
What is the survival rate?
It remains low compared with most cardiac conditions, and it depends heavily on how quickly blood flow is restored and on which organs have failed. Rather than quote a single figure that will not apply to any individual, the honest answer is that outcomes are substantially better when treatment starts early — which is the entire basis of the public message.
Can you survive cardiogenic shock?
Yes, many people do. Survival has improved with early revascularisation and mechanical circulatory support, and recovery is possible, though it typically involves intensive care, a period of rehabilitation, and long-term cardiac management.
Does a supplement help?
No. There is no supplement that treats cardiogenic shock. Anything marketed for “circulation support” is irrelevant to a pump failure emergency, and relying on one instead of calling for help could be fatal.
Is cardiogenic shock the same as a heart attack?
No, but they are closely related. A heart attack is a blockage; cardiogenic shock is a complication of a large one, where the damage causes the pump to fail. Most cases follow a heart attack, but not every heart attack causes shock.
Can it happen without a previous heart attack?
Yes — severe arrhythmias, myocarditis, acute valve failure and advanced cardiomyopathy can all cause it. These are less common but not rare, which is why the symptom list matters independent of cardiac history.
What is recovery like?
Typically a stay in intensive care, often with mechanical support, followed by a staged recovery and cardiac rehabilitation. Many people have persistent fatigue and reduced exercise capacity for months. Cardiac rehabilitation programmes have good evidence for improving outcomes afterwards, and are worth asking about.
Sources
- Sarma D, et al. Cardiogenic shock: pathogenesis, classification and management. Crit Care Clin. 2024. PMID 37973356
- Samsky MD, et al. Cardiogenic shock after acute myocardial infarction: a review. JAMA. 2021. PMID 34751704
- Jung C, et al. Management of cardiogenic shock: state-of-the-art. Intensive Care Med. 2024. PMID 39254735
- Shekhar S, et al. Cardiogenic shock: current evidence, guideline perspectives and outcomes. J Cardiothorac Vasc Anesth. 2026. PMID 41720700
- Rob D, et al. The mechanical support of cardiogenic shock. Curr Opin Crit Care. 2021. PMID 33929344
- Singh S, et al. Acute kidney injury in cardiogenic shock: an updated narrative review. J Cardiovasc Dev Dis. 2021. PMID 34436230
- Jentzer JC, et al. Vasopressor and inotrope therapy in cardiac critical care. J Intensive Care Med. 2021. PMID 32281470
- De Backer D, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010. PMID 20200382
- Syed M, et al. Sixteen-year national trends in use and outcomes of VA-ECMO in cardiogenic shock. Cardiovasc Revasc Med. 2022. PMID 35853815
- Thompson AD, et al. Cardiac intensive care rehabilitation and post-acute outcomes. Eur Heart J Acute Cardiovasc Care. 2026. PMID 42160216
